Alpargatas S.A (ALPA3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 12.90 |
|---|---|
| 52-week range | 7.81 – 13.49 |
| Return, 1 month / 3 months | +34.4% / +37.2% |
| Return, 1 year / 3 years | +61.1% / +91.3% |
| Trend | Uptrend |
| RSI (14) | 76 |
| Volatility (1 year) | 50.4% |
| Worst drawdown (1 year) | -35.9% |
| Average daily value traded | 0.13M BRL |
| Dividend yield | 13.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alpargatas S.A. is a Brazilian company that makes footwear and apparel. Its main products are flip-flops and sandals sold under the Havaianas brand, along with casual shoes and clothing. The company serves retail customers in Brazil and exports its products to markets around the world. It is based in Brazil and sells through shops, distributors and online channels to consumers who want casual, everyday footwear.
On this site Alpargatas S.A appears as a stock on the Sao Paulo Exchange (Brazil), code ALPA3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alpargatas S.A (ALPA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 12.90 on 16 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 409 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 61.1% and over the last three months it rose 37.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.8% | ||
| From 52-week high | -3.2% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 37.2% | ||
| 6-month return | 16.6% | ||
| 12-month return, skipping the last month | 19.9% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.9% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.13M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 13.5% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +11.9% |
|---|---|
| 1 month | +34.4% |
| 3 months | +37.2% |
| 6 months | +16.6% |
| 1 year | +61.1% |
| 3 years | +91.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 10.26 / 10.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Dec 2025 | BRL 0.4918 |
| 18 Nov 2025 | BRL 1.2540 |
| 27 Feb 2025 | BRL 0.0967 |
| 30 Dec 2021 | BRL 0.1483 |
| 3 Nov 2021 | BRL 0.2472 |
| 14 Feb 2020 | BRL 0.0502 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.